Aptar Group, the US-based drug and consumer product delivery solutions has broken ground for its new pharma plant in Taloja, near Mumbai.

The new facility will expand the company’s existing footprint in the region while adding additional local production of several technologies including Aptar’s pressurized metered dose inhaler (pMDI) valve, as well as breath-actuated devices and single-dose nasal sprays. 

The company helps Indian pharmaceutical companies in launching inhalers and nasal sprays domestically and for export markets. For the company, the new Taloja plant will adding an additional 4,400 sq. mtrs. of manufacturing footprint and it will be constructed adjacent to the existing Aptar Mumbai facility which opened in 2023. 

Aptar is looking for potential acquisitions and partnerships with IP driven, pharma packaging companies to continue the expansion of their drug dosing, dispensing and protection offerings. The company is a provider of inhalation devices which assists in delivery of the drugs used to treat respiratory diseases such as asthma and COPD.